Darbecure 25mcg Injection
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Darbepoetin alfa (25mcg)
Overview Darbecure 25mcg Injection
Erythropoietin injection (25 mcg) treats anemia resulting from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation for increased red blood cell production. This medication demands careful administration due to potential severe adverse reactions; expert medical oversight is crucial. Strict adherence to physician instructions is mandatory, as administration occurs under professional supervision. Common side effects encompass abdominal discomfort, hypertension, skin rash, injection site pain, dyspnea, cough, and peripheral swelling. Report symptoms of significantly elevated blood pressure—including intense headache, visual disturbances, nausea, vomiting, or convulsions—immediately. Regular blood tests to monitor electrolyte (potassium) levels, hemoglobin, and blood cell counts are typically conducted. Discontinue use and consult your physician if shortness of breath or a skin eruption occurs. Prior to commencing treatment, disclose any history of heart disease, hypertension, seizures, or strokes. Pregnant, breastfeeding, or planning pregnancy/breastfeeding women should consult their doctor regarding safety.
Uses of Darbecure 25mcg Injection
Managing anemia associated with chronic kidney failure | Addressing chemotherapy-induced anemia
Major Benefits of Darbecure 25mcg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Darbecure 25mcg Injection:
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Darbecure 25mcg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Darbecure 25mcg Injection works:
Darbepoetin alfa 25 mcg injection boosts red blood cell production. This erythropoiesis-stimulating agent (ESA) acts by prompting increased red blood cell generation within the bone marrow.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol with Darbecure 25mcg Injection is undetermined; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Darbecure 25mcg Injection during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The administration of Darbecure 25mcg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingSAFE
Administration of Darbecure 25mcg Injection typically does not impair driving ability.
KidneySAFE IF PRESCRIBED
Administration of Darbecure 25mcg Injection is considered safe for individuals with renal impairment. No modification of the Darbecure 25mcg Injection dosage is necessary.
LiverCAUTION
For individuals with hepatic impairment, administration of Darbecure 25mcg Injection requires careful monitoring. Dosage modification of Darbecure 25mcg Injection might be necessary. Physician consultation is recommended.
What if you forget to take Darbecure 25mcg Injection :
Should you forget a Darbecure 25mcg Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Darbecure 25mcg Injection
| Label | Value |
|---|---|
| Chemical Classification | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Type of Therapy | KINSHIP |
| Actions | Erythropoietin-stimulating drug |
3,018 People bought this recently